- Home
- STG vs ASRT Comparison
STG vs ASRT Comparison
Compare STG & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STG
- ASRT
- Stock Information
- Founded
- STG 2003
- ASRT 1995
- Country
- STG China
- ASRT United States
- Employees
- STG N/A
- ASRT N/A
- Industry
- STG Other Consumer Services
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- STG Real Estate
- ASRT Health Care
- Exchange
- STG Nasdaq
- ASRT Nasdaq
- Market Cap
- STG 70.3M
- ASRT 57.9M
- IPO Year
- STG 2018
- ASRT 1997
- Fundamental
- Price
- STG $5.43
- ASRT $0.65
- Analyst Decision
- STG
- ASRT Strong Buy
- Analyst Count
- STG 0
- ASRT 2
- Target Price
- STG N/A
- ASRT $3.25
- AVG Volume (30 Days)
- STG 4.7K
- ASRT 207.4K
- Earning Date
- STG 08-15-2025
- ASRT 08-06-2025
- Dividend Yield
- STG N/A
- ASRT N/A
- EPS Growth
- STG N/A
- ASRT N/A
- EPS
- STG 3.09
- ASRT N/A
- Revenue
- STG $269,356,990.00
- ASRT $119,001,000.00
- Revenue This Year
- STG N/A
- ASRT N/A
- Revenue Next Year
- STG N/A
- ASRT $11.91
- P/E Ratio
- STG $1.76
- ASRT N/A
- Revenue Growth
- STG N/A
- ASRT N/A
- 52 Week Low
- STG $4.25
- ASRT $0.51
- 52 Week High
- STG $11.06
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- STG 49.16
- ASRT 49.30
- Support Level
- STG $6.05
- ASRT $0.60
- Resistance Level
- STG $6.23
- ASRT $0.68
- Average True Range (ATR)
- STG 0.35
- ASRT 0.03
- MACD
- STG -0.07
- ASRT -0.00
- Stochastic Oscillator
- STG 8.69
- ASRT 67.00
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.